New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

The net benefit for detecting clinically significant prostate cancer (csPC) is greater with Stockholm3 vs PSA, according to findings from a large prospective study published in th ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are truly dangerous. Our results show that Stockholm3 identifies significantly ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision should begin with a conversation about the risks and benefits of testing. But a ...

PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...

"A lot of people assume that if their doctor doesn't bring up prostate cancer screening, it must not be important. But ...

Prostate cancer is often called a “silent killer,” and for good reason. You don’t get a big set of warnings, and for a lot of ...